At the heart of the Oncopole of Toulouse, the CRCT, together with all its partners (institutional, academic, clinical, industrial, charities…), stimulates innovation in terms of research and teaching in the fight against cancer.
The CRCT is a joint Research Unit Inserm & University Toulouse III Paul Sabatier
3 research teams are also labelled by the CNRS
Research teams
Platform facilities
Researchers, clinicians and supports
PhD students and post-doctoral fellows
News
Reprogram a family of lipids to increase the efficacy of melanoma immunotherapy.
Immunotherapy for advanced melanoma has revolutionized the treatment of this deadly cancer. However, almost half of patients do not respond to this treatment and die within 5 years after starting treatment. Our work shows that melanoma cells exhibit alterations in the...
Rapid detection of a cancer biomarker by a microfluidic chip
Researchers from LAAS-CNRS, in collaboration with the Toulouse Cancer Research Centre, have shown how μLAS microfluidic chip technology can concentrate and measure microRNAs, cancer biomarkers, in less than a minute. MicroRNAs (miRs) are short fragments of RNA that...
The cell signalling enzymes PI3Kalpha and PI3Kβ play major roles in the body.
PI3Ks are important molecules, that, by adding a tag on a lipid, induce messages (also called signals) in the cells. They are hence key regulators of cell signalling. In the animals of higher order, such as Humans, PI3Ks come in different flavours. In particular, the...
CRCT upcoming events
Calendar
Find us
Centre de Recherches en Cancérologie de Toulouse
2 avenue Hubert Curien
31037 TOULOUSE CEDEX 1 – FRANCE
Contact us
Tel : +33(0) 5 82 74 15 75
Fax : +33(0) 5 82 74 16 85
| Contact form